7Riddle MC, Rosenstock J, Gerich J. The treat to target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care, 2003,26:3080-3086.
8Janka HU, Plewe G, Riddle MC, et al. Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes. Diabetes Care, 2005,28:254-259.
9Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA1c. Diabetes Care, 2003,26:881-885.
10Rizzo MR, Barbieri M, Grella R, et al. Repaglinide is more efficient than glimepiride on insulin secretion and postprandial glucose excursions in patients with type 2 diabetes. A short term study. Diabetes Metab, 2004,30:81-89.
